You've been treating a patient for depression for three months. Are they getting better? Staying the same? Getting worse?
Clinical judgment remains essential, but gradual changes can be difficult to reconstruct from memory alone. Repeated questionnaires add a consistent symptom record for review.
Measurement-based care adds that record with questionnaires such as the PHQ-9 or GAD-7. The scores describe answers at each time point. They do not confirm a diagnosis or establish why a change occurred.
What measurement-based care actually means
Measurement-based care (MBC) is the practice of routinely collecting patient symptom data with appropriate published questionnaires and reviewing that data during care. Three elements define it:
Routine collection: Giving standardized assessments at every or most treatment sessions, not just at intake and discharge. This differs from traditional outcome monitoring, which might happen every 90 days during treatment reviews.
Clinical use: Reviewing the data instead of filing it away. Scores can frame questions and document symptom patterns, while the interview, functioning, risk, history, and patient preferences inform treatment decisions.
Collaborative sharing: Discussing results with patients as part of treatment. The questionnaire becomes a shared point of discussion rather than a verdict.
The evidence
Randomized trials and systematic reviews have compared MBC with usual care and reported group-level differences in symptom and remission outcomes. Those findings support measurement as a clinical workflow. They do not make an individual's score change proof that treatment caused improvement.
Regular feedback can prompt earlier review when reported symptoms change or remain high. The clinician still has to determine whether the pattern reflects treatment, adherence, life events, measurement variation, or something else.
Why clinicians believe in MBC but don't use it
Measurement-based care remains inconsistently implemented.
The barriers are practical: time constraints in packed schedules, EHR systems not designed for MBC data, limited training on implementation, and the inertia of established practice. These are solvable problems, not fundamental objections.
The three components
Measure selection: Choose instruments that are clinically relevant, brief (2-3 minutes), validated, and sensitive to change. The PHQ-9 for depression and GAD-7 for anxiety are standard choices. For PTSD, the PCL-5 (20 items, 5-10 minutes) or the faster PC-PTSD-5 screener work well. Ultra-brief options like the PHQ-2 and GAD-2 exist for high-volume settings.
Routine administration: Choose an interval that matches the questionnaire's recall period, the treatment phase, and local protocol. Consistent timing makes comparisons easier to interpret.
Clinical integration: Review scores before sessions. Discuss with patients: "Your anxiety score dropped from 14 to 9 this month. What do you think contributed to that?" Use the answer as one part of clinical reasoning. Do not let the total select an intervention.
What MBC looks like in practice
Before seeing a patient, review current scores, comparison to baseline, trajectory over recent sessions, and any item-level safety signals. You enter the session with structured context.
Early in the session, reference the data: "I see your PHQ-9 score was 12 this week, similar to last week. You've been steady in the moderate range for about a month. How does that match how you've been feeling?"
Use scores to guide questions. A lower total may prompt a discussion about what changed. A flat or higher total may prompt review of symptoms, function, adherence, adverse effects, and context. The score alone does not tell you to continue, augment, switch, refer, or change monitoring.
Document in progress notes: assessment administered and score, comparison with previous scores, relevant item responses, the patient's account, clinical interpretation, and reasoning. Example: "PHQ-9 = 8, down from 14 at baseline 8 weeks ago. Patient reports improved sleep and work attendance. Reviewed the full assessment before setting the plan."
Implementation
Start small. One assessment (PHQ-9 is a good starting point), new patients only, one clinician. Build expertise before scaling.
Make collection automatic. Automated delivery, scoring, and review queues reduce administrative steps. Configure totals as prompts for review, while item-level safety responses follow the practice's safety protocol.
Train your team on the workflow, the limits of each score, the review protocol, and how to discuss results with patients. Follow initial training with consultation and support.
Explain the purpose to patients: "I'm going to ask you to complete a brief questionnaire before each appointment. It gives us the same symptom check-in over time and something concrete to discuss."
For organizations
Aggregate MBC data shows score patterns across a practice. Organizations can review completion, missing data, and changes in reported symptoms. These aggregates do not establish diagnosis, treatment effect, or quality by themselves.
Score changes can enter a review queue. A clinician decides whether a patient needs outreach or a different care plan after reviewing the full record.
The core workflow is simple: collect the same measure consistently, review it with the patient, and document how it informed the broader assessment.